Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model

Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model

Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) are highly expressed in nasopharyngeal carcinoma; therefore, blocking the binding of VEGF and VEGFR may be a potential way to treat nasopharyngeal carcinoma. Apatinib inhibits tumor angiogenesis. Previous studies have suggested that...

Full description

Bibliographic Details
Main Authors: Shanshan Liu MD, Fei Wu MD, Yanling Zhang MD, Rongsheng Qin MD, Nengping Zhu MD, Yuan Li MD, Mingting Wang MD, Qin Zeng MD, Danna Xie MD, Yinghua Li MD, Juan Fan MD, Yunwei Han PhD
Format: Article
Language:English
Published: SAGE Publishing 2020-05-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/1073274820922553

Similar Items

Similar Items